001540 — AHN-GOOK PHARMACEUTICAL Co Balance Sheet
0.000.00%
- KR₩97bn
- KR₩116bn
- KR₩271bn
- 80
- 97
- 41
- 88
Annual balance sheet for AHN-GOOK PHARMACEUTICAL Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS/A | ARS/A | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | — | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 48,592 | 46,209 | 36,092 | 35,446 | 29,738 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 37,893 | 44,159 | 55,597 | 62,753 | 59,015 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 111,432 | 116,285 | 122,010 | 135,416 | 134,772 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 70,554 | 70,911 | 70,771 | 73,036 | 120,069 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 206,984 | 219,956 | 223,912 | 238,598 | 302,535 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 44,678 | 52,212 | 61,498 | 78,242 | 77,059 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 57,603 | 66,535 | 69,115 | 86,511 | 136,860 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 149,380 | 153,421 | 154,798 | 152,086 | 165,676 |
| Total Liabilities & Shareholders' Equity | 206,984 | 219,956 | 223,912 | 238,598 | 302,535 |
| Total Common Shares Outstanding |